UM
URIST MARSHALL disclosed sale in Royalty Pharma plc
URIST MARSHALL, EVP, Research & Investments, disclosed a sale transaction in Royalty Pharma plc (RPRX) on 2026-05-20.
Action
Sale
Capital
$721,838 reported value
Insider Form 4 Activity1 evidence source
Why it matters
Insider Form 4 disclosures can surface management and director trading activity. This card is generated from pre-ingested disclosure data, not from request-time scraping.